Cresset Asset Management’s Orthofix Medical OFIX Stock Holding History

Cresset Asset Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14	Closed	-$1K	–	1294
2019 Q1	$1K	Hold	14	–	–	﹤0.01%	1835
2018 Q4	$1K	Buy	+14	New	+$796	﹤0.01%	1550

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cresset Asset Management's OFIX Position: Q2 2019 in Review

Cresset Asset Management sold out of Orthofix Medical (OFIX) in Q2 2019, closing a stake of 14 shares — an estimated $1K sold.

Cresset Asset Management first reported a position in OFIX in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 157 funds tracked by Wall St. Rank hold OFIX as of Q2 2019.

Cresset Asset Management reported no remaining Orthofix Medical position as of Q2 2019 after selling out during the quarter.
Cresset Asset Management sold 14 Orthofix Medical shares in Q2 2019, an estimated $1K.
Cresset Asset Management first reported a position in Orthofix Medical in Q4 2018 and held it in 2 quarters.
Cresset Asset Management's Orthofix Medical position peaked at $1K in Q1 2019.
157 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.